| |
| |
|
| Insider
Information: |
Lin Shao-Lee |
| Relationship: |
Chief Executive Office... |
| City: |
Dublin |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,718,758 |
|
|
Indirect Shares
|
1,874,955 |
|
|
| Direct
Value |
$9,523,362 |
|
|
|
Indirect Value
|
$7,724,815 |
|
|
| Total
Shares |
3,593,713 |
|
|
| Total
Value |
$17,248,176 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -135.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Horizon Pharma, Inc. |
HZNP |
EVP, Head of R&D and CSO |
2020-01-05 |
106,255 |
2019-01-04 |
0 |
Premium* |
|
|
Surrozen Ord Shs |
SRZN |
Director |
2021-08-11 |
35,129 |
|
0 |
Premium* |
|
|
Acelyrin, Inc. |
SLRN |
Chief Executive Office... |
2024-04-01 |
1,577,374 |
2024-04-01 |
1,874,955 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
26 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
26 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
